CJC-1295/Ipamorelin Blend Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about CJC-1295/Ipamorelin Blend dosing — protocols, safety, and where to buy.
Dose Range
Not human dosing guidance. Vendor blends are typically pre-mixed at a fixed ratio - commonly around 100 mcg CJC-1295 (mod GRF 1-29) to 100-200 mcg Ipamorelin per unit. Community-reported figures only; no clinically established dose exists.
Frequency
1–2 times daily; bedtime injection most common
Cycle Length
8–16 weeks; can be used long-term with periodic 4-week breaks
Half-Life
CJC-1295 as mod GRF 1-29 (no DAC): ~30 minutes. Ipamorelin: ~2 hours. The long-acting CJC-1295 with DAC is far longer - an estimated 5.8-8.1 days in its Phase I characterization [PMID:16352683] - but standard blends use the short-acting no-DAC form.
Administration Routes
Quick Reconstitution Calculator
Calculate syringe units instantly
Syringe Draw
10.0 units
2500 mcg/ml · 0.100 ml draw
For laboratory research use only. This tool performs reconstitution math (concentration and syringe-unit conversion) and is not dosing guidance for humans or animals.
Dosing Protocols
Research-use-only material; this is not human dosing guidance. Community-reported (non-clinical) accounts describe a single subcutaneous injection at night, on an empty stomach (roughly 2+ hours after eating), run in blocks of about 8-12 weeks. Anecdotal only - no clinical trials support any human protocol for this blend.
Research-use-only material; not human dosing guidance. Community-reported (non-clinical) accounts describe two injections per day - a fasted morning dose and a bedtime dose - over roughly 12 weeks. These reflect user anecdote, not clinical evidence.
Research-use-only material; not human dosing guidance. Community-reported (non-clinical) accounts describe two injections daily over roughly 16 weeks, sometimes paired with oral MK-677 at night for a more sustained GH baseline. Higher-exposure anecdotes carry greater uncertainty and risk and have no clinical validation.
Weight-Based Dosing
Commonly Stacked With
Already a synergistic stack. Can add MK-677 for 24-hour GH baseline, BPC-157/TB-500 for recovery, or AOD-9604 for fat loss.
Side Effects & Safety
Contraindications
Active cancer. Pituitary disorders. Pregnancy or breastfeeding.
Additional Notes
Research-use-only material. The notes below describe general lab handling and community practice, not human dosing guidance. Reconstitute per vendor instructions and store refrigerated after reconstitution; protect from light and heat and avoid repeated freeze-thaw cycles. A pre-mixed blend keeps the GHRH-analog-to-GHRP ratio fixed and simplifies handling versus two separate vials. It remains one of the more commonly researched growth-hormone-secretagogue pairings.
Where to Buy CJC-1295/Ipamorelin Blend
Compare 4 listings across 4 vendors — from $49.99
Frequently Asked Questions
What is the recommended CJC-1295/Ipamorelin Blend dosage?
The typical dose range for CJC-1295/Ipamorelin Blend is Not human dosing guidance. Vendor blends are typically pre-mixed at a fixed ratio - commonly around 100 mcg CJC-1295 (mod GRF 1-29) to 100-200 mcg Ipamorelin per unit. Community-reported figures only; no clinically established dose exists.. It is usually administered 1–2 times daily; bedtime injection most common. Always start with the lowest effective dose.
How often should I take CJC-1295/Ipamorelin Blend?
1–2 times daily; bedtime injection most common
Does CJC-1295/Ipamorelin Blend need to be cycled?
Yes, typical cycle length is 8–16 weeks; can be used long-term with periodic 4-week breaks.
What are CJC-1295/Ipamorelin Blend side effects?
Nausea, flushing, headache, fatigue. Potential water retention. At high doses: anxiety, restlessness. Injection site irritation.
Where can I buy CJC-1295/Ipamorelin Blend?
Compare 4 listings from 4 vendors on our price comparison page — starting from $49.99.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Reconstitution math, concentration charts, half-lives, and vendor trust tiers. The reference we wish we had on day one.